presenc
foreign
materi
tracheal
tube
stomach
tube
facilit
colonis
upper
airway
digest
tract
endogen
exogen
microorgan
tracheal
contamin
origin
bacteri
aspir
result
passag
secret
around
cuff
tracheal
tube
accumul
tracheal
rare
vap
aris
contamin
stagnant
water
ventil
circuit
use
colonis
aerosol
contamin
contigu
site
almost
exclus
pleural
caviti
enhanc
knowledg
pathophysiolog
vap
led
develop
effect
prevent
strategi
vap
prevent
measur
recommend
french
consensu
confer
nosocomi
infect
state
orotrach
rout
use
tracheal
intub
instead
nasal
tracheal
cuff
pressur
maintain
cm
also
recommend
use
sedationanalgesia
algorithm
facilit
earli
wean
ventil
avoid
unplan
prioritis
use
noninvas
ventil
follow
recognis
place
patient
semirecumb
posit
regularli
decontamin
nasal
oropharyng
caviti
suitabl
mouth
start
enter
nutrit
earli
combin
system
antibiot
therapi
select
digest
decontamin
may
recommend
implement
requir
specif
modal
choic
dose
durat
select
digest
decontamin
antibiot
therapi
target
popul
maintain
suffici
level
pressur
tracheal
tube
cuff
critic
import
pressur
low
patient
risk
inhal
accumul
subglott
secret
oropharynx
known
play
major
role
vap
altern
pressur
high
risk
ischaemia
tracheal
mucosa
remov
tracheal
oedema
later
tracheal
stenosi
therefor
regular
monitor
tracheal
cuff
pressur
recommend
optim
monitor
frequenc
yet
clearli
determin
underinfl
andor
overinfl
tracheal
cuff
often
occur
ventil
patient
intermitt
manual
control
tracheal
cuff
pressur
use
manomet
wellknown
sourc
morbid
recent
publish
data
favour
use
automat
devic
abl
continu
regul
tracheal
cuff
even
though
sever
learn
societi
recommend
implement
purpos
vap
prevent
ventil
patient
recent
find
literatur
tend
favour
howev
studi
sever
limit
monocentr
studi
includ
rel
small
number
particip
rare
includ
sever
trauma
patient
even
though
greatest
risk
vap
studi
systemat
appli
recommend
vap
prevent
measur
contest
choic
main
studi
end
point
two
method
continu
regul
tracheal
cuff
pressur
avail
pneumat
electron
publish
studi
favour
due
better
reactiv
fewer
period
insuffici
excess
tracheal
cuff
pressur
consequ
reduc
risk
microb
inhal
tracheal
injuri
addit
low
acquisit
cost
eas
use
electr
suppli
requir
object
studi
determin
whether
continu
regul
tracheal
cuff
pressur
use
mechan
pneumat
regul
devic
nosten
leve
pari
superior
intermitt
control
tracheal
cuff
pressur
reduc
incid
vap
sever
trauma
patient
receiv
recommend
method
vap
prevent
individu
level
benefit
expect
includ
shorter
durat
mechan
ventil
stay
icu
well
improv
patient
outcom
collect
level
addit
reduc
cost
hospit
stay
number
day
antibiot
also
declin
along
select
pressur
perpetu
emerg
multidrugresist
bacteria
agat
trial
multicentr
randomis
control
openlabel
clinic
trial
two
parallel
group
primari
end
point
proport
patient
develop
vap
icu
day
randomis
carri
secur
webbas
randomis
system
stratifi
centr
sever
patient
unconsci
time
inclus
glasgow
coma
scale
lower
higher
equal
patient
consid
candid
inclus
studi
meet
inclus
criteria
none
exclus
criteria
box
patient
suffer
sever
trauma
admit
within
first
hour
requir
invas
mechan
ventil
expect
last
longer
hour
includ
studi
case
patient
inclus
take
place
soon
possibl
icu
admiss
hour
follow
trauma
andor
hour
follow
oral
intub
trachea
pregnant
lactat
women
includ
studi
materi
use
present
specif
risk
teratogenicitybox
exclus
criteria
inclus
criteriapati
age
least
yearssuff
sever
trauma
defin
injuri
sever
score
tracheal
intub
via
oral
rout
hoursrequir
mechan
ventil
expect
length
hoursparticip
social
secur
scheme
benefit
scheme
mean
third
parti
exclus
criteriapati
like
die
hour
follow
admissionhav
trachea
intub
via
nasal
routepati
intub
tracheal
tube
subglott
secret
drainagehav
trachea
intub
hour
traumab
ventil
tracheotomyrefus
particip
researchhav
contraind
headup
positionparticip
anoth
research
protocol
pertain
antiinfect
treatment
measur
decreas
risk
infectionbenefit
reinforc
protect
person
depriv
freedom
subsequ
legal
administr
decis
major
legal
protect
patient
includ
studi
randomis
one
two
treatment
group
base
method
use
monitor
tracheal
cuff
pressur
benefit
daili
monitor
throughout
hospit
stay
icu
follow
criteria
appli
patient
control
throughout
durat
studymonitor
tracheal
cuff
pressur
tracheal
tube
either
everi
hour
control
group
continu
intervent
group
use
pneumat
devic
nosten
object
maintain
pressur
cm
ident
sedat
wean
protocol
centresimplement
lung
protect
ventil
maintain
tidal
volum
mlkg
ideal
bodi
weight
posit
endexpiratori
pressur
cm
respiratori
rate
set
achiev
normocapnia
option
moder
hypocapniaaccord
protocol
observ
unit
extub
consid
soon
patient
glasgow
coma
scale
patient
cough
spontan
secondari
bronchial
aspir
level
pressur
support
cm
spontan
ventil
tpiec
lower
toler
patient
least
minno
systemat
chang
respir
circuitspreferenti
use
heat
humid
exchang
filter
chang
soiledsystemat
applic
bed
inclin
least
monitor
everi
hourshand
wash
hydroalcohol
friction
prior
treatment
follow
isol
measuresmouth
care
everi
hour
accord
protocol
observ
unittrach
aspir
carri
use
steril
equip
perform
requiredpreferenti
oral
insert
feed
tubesstart
enter
feed
soon
possiblesystemat
applic
glucos
monitor
protocol
patient
blood
sugar
level
measur
everi
hour
object
maintain
glucos
level
mmollprophylact
antibiot
treatment
limit
hour
fractur
oper
within
first
hourscur
antibiot
therapi
reserv
infect
bacteri
origin
document
probabl
case
antiinfecti
measur
insuffici
accord
recommend
offici
french
health
author
proper
use
adequ
dosag
regimen
method
antibiot
administr
provid
ensur
optim
concentr
site
infect
recours
serum
assay
use
whenev
possibl
avoid
underdos
common
caus
failur
well
avoid
overdos
lead
iatrogen
patholog
narrowspectrum
antibiot
prefer
case
sever
infect
antibiot
treatment
start
soon
possibl
follow
diagnost
microbiolog
sampl
start
later
first
hour
case
septic
shock
durat
vap
treatment
limit
week
except
case
nonfer
gramneg
bacteri
infect
antibiot
therapi
continu
week
reduc
risk
recurr
antibiot
associ
strictli
limit
precis
defin
situat
need
broaden
antibacteri
spectrum
sever
microbiolog
undocu
infect
pseudomona
aeruginosa
infect
bacteria
antibiot
combin
associ
high
risk
resist
emerg
includ
group
enterobacteriacea
eg
enterobact
serratia
citrobact
freundii
providencia
morganella
thirdgener
cephalosporin
staphylococcu
aureu
fluoroquinolon
rifampicin
fusid
acid
fosfomycin
enterobacteriacea
resist
nalidix
acid
fluoroquinolon
antibiot
therapi
reevalu
hoursprevent
ulcer
diseas
proton
pump
inhibitor
accord
protocol
observ
centr
attempt
detect
vap
sign
perform
daili
basi
patient
mechan
ventil
accord
definit
establish
at
box
thorac
xray
aim
detect
vap
carri
within
hour
whenev
least
two
follow
clinic
sign
vap
observ
clinic
examin
fever
hypothermia
purul
endotrach
secret
either
hyperleucocytosi
leucopenia
whenev
patient
meet
clinic
radiolog
criteria
day
vap
suspect
modifi
clinic
pulmonari
infect
score
calcul
present
tabl
bacteri
analysi
respiratori
tract
carri
especi
calcul
score
type
sampl
bronchoalveolar
lavag
blind
distal
sampl
tracheal
aspir
left
discret
attend
physician
depend
procedur
unit
patient
suspect
develop
vap
two
assessor
mask
group
assign
review
casereport
form
classifi
case
accord
accept
definit
patient
monitor
randomis
discharg
icu
without
exceed
day
follow
inclus
evalu
assess
criteria
carri
depend
durat
patient
stay
icuevalu
carri
discharg
icu
patient
icu
stay
daysevalu
carri
day
discharg
icu
patient
icu
stay
daysevalu
carri
day
patient
icu
stay
day
patient
leav
icu
consid
exit
studi
readmiss
icu
even
within
day
follow
trauma
taken
account
event
occur
first
icu
discharg
consid
assess
criteria
patient
exit
studi
wish
without
provid
justif
qualiti
care
alter
outcom
taken
account
final
analysi
number
particip
group
base
estim
vap
incid
patient
control
group
reduc
vap
incid
halv
intervent
group
studi
power
p
valu
bilater
situat
vap
incid
control
group
chosen
basi
unpublish
analysi
databas
french
research
network
devot
studi
trauma
given
recruit
potenti
centr
approach
particip
studi
togeth
constraint
associ
protocol
expect
inclus
durat
set
month
patient
admit
icu
french
univers
hospit
screen
enrol
within
hour
trauma
patient
enrol
decid
attend
physician
computergener
number
list
provid
statistician
involv
either
screen
patient
assess
outcom
randomis
carri
use
secur
webbas
randomis
system
stratif
centr
sever
unconsci
time
inclus
glasgow
coma
scale
account
differ
patient
treatment
centr
heighten
vap
risk
patient
glasgow
coma
scale
patient
randomli
assign
one
two
treatment
group
base
method
use
monitor
tracheal
cuff
pressur
mask
particip
icu
staff
feasibl
due
natur
devic
place
close
patient
face
howev
microbiologist
test
pulmonari
blood
sampl
outcom
assessor
nm
om
statistician
mask
group
assign
independ
clinic
research
assist
avail
particip
hospit
help
run
studi
data
collect
studi
document
deidentifi
store
year
per
protocol
nonclin
trial
notif
ctn
intervent
studi
data
electron
store
doubl
passwordprotect
comput
hard
copi
data
clinic
research
file
store
lock
secur
offic
personnel
involv
data
analysi
mask
princip
investig
statistician
access
final
data
set
analys
perform
follow
intentiontotreat
principl
randomis
patient
except
withdrew
consent
statist
analys
take
account
stratifi
randomis
centr
glasgow
coma
scale
recommend
consolid
standard
report
trial
consort
guidelin
studi
report
categor
variabl
report
number
percentag
continu
variabl
summaris
use
mean
median
iqr
normal
nonnorm
distribut
data
along
respect
ci
analys
primari
end
point
secondari
end
point
relat
vap
incid
use
logist
regress
model
adjust
stratif
factor
covari
significantli
imbalanc
group
cumul
event
curv
time
first
vap
diagnosi
estim
use
kaplanmei
procedur
number
ventilatorfre
day
vfd
number
day
patient
success
wean
mechan
ventil
end
point
day
day
defin
follow
patient
die
within
day
requir
mechan
ventil
day
vfd
patient
success
wean
mechan
ventil
within
day
x
number
day
mechan
ventil
number
antibioticfre
day
afd
number
day
live
patient
receiv
antibiot
day
prophylact
cur
antibiot
therapi
relat
trauma
consid
vfd
afd
assess
manner
compar
group
use
regress
model
allow
adjust
stratif
factor
categor
secondari
end
point
compar
group
use
logist
regress
model
statist
analys
conduct
use
sa
softwar
miss
data
describ
number
correspond
percentag
group
presenc
imbal
proport
miss
data
treatment
group
evalu
use
logist
regress
model
assess
robust
result
case
miss
data
sensit
analys
perform
imput
miss
data
worst
valu
failur
death
etc
multipl
imput
clinic
research
associ
ensur
patient
inclus
data
collect
registri
rapport
line
protocol
studi
conduct
accord
good
clinic
practic
guidelin
furthermor
verifi
follow
variabl
patient
initi
date
birth
sex
sign
consent
form
elig
criteria
date
randomis
treatment
assign
advers
event
studi
end
point
clinic
trial
carri
line
principl
declar
helsinki
accord
clinic
trial
direct
european
parliament
approxim
law
regul
administr
provis
member
state
relat
implement
good
clinic
practic
conduct
clinic
trial
medicin
product
human
use
ethic
aspect
research
project
approv
ethic
committe
poitier
univers
hospit
franc
ethic
committe
poitier
approv
cover
particip
site
trial
monitor
research
monitor
offic
poitier
univers
hospit
prior
consent
subject
possibl
therefor
consent
subject
legal
accept
repres
request
consent
form
specif
design
subject
legal
accept
repres
provid
document
approv
favour
opinion
institut
review
board
order
protect
right
safeti
wellb
subject
ensur
complianc
applic
regulatori
requir
nonobject
particip
studi
patient
rel
solicit
accord
requir
ethic
committe
peopl
direct
access
data
take
necessari
precaut
maintain
confidenti
data
collect
studi
render
anonym
initi
inclus
number
regist
result
studi
releas
particip
physician
refer
physician
medic
commun
later
year
complet
trial
present
scientif
confer
public
peerreview
journal
incid
vap
primari
end
point
trial
howev
vap
diagnosi
may
difficult
perform
icu
sever
criteria
report
perform
trial
vap
incid
determin
accord
at
choic
could
challeng
howev
criteria
commonli
use
vap
diagnosi
literatur
also
record
vae
accord
cdc
compar
at
cdc
definit
vap
secondari
object
halv
vap
rate
could
seem
ambiti
singl
intervent
howev
find
report
two
previou
studi
assess
clinic
impact
continu
control
devic
cuff
mouth
care
stress
ulcer
prophylaxi
base
local
written
protocol
may
act
potenti
confound
variabl
howev
control
stratif
randomis
centr
level
adjust
statist
analys
case
differ
group
final
mask
feasibl
due
natur
intervent
howev
end
point
assess
two
assessor
mask
group
assign
order
minimis
bia
conclus
trial
first
multicentr
randomis
control
openlabel
studi
adequ
power
test
hypothesi
continu
pneumat
regul
tracheal
cuff
pressur
prevent
vap
mechan
ventil
sever
trauma
patient
univers
hospit
poitier
professor
olivi
mimoz
univers
hospit
anger
professor
sigismond
lasocki
univers
hospit
beaujon
professor
catherin
paugam
univers
hospit
professor
jacqu
durnteau
univers
hospit
clermontferrand
professor
jeanmichel
constantin
univers
hospit
grenobl
professor
payen
univers
hospit
marseil
professor
marc
leon
univers
hospit
nant
professor
karim
asehnoun
univers
hospit
nice
professor
carol
ichai
univers
hospit
professor
jeanyv
lefrant
univers
hospit
rouen
professor
benoit
veber
univers
hospit
strasbourg
professor
julien
pottech
univers
hospit
professor
piliflouri
univers
hospit
dijon
professor
belaid
bouhemad
univers
hospit
nanci
professor
audibert
franc
trial
current
progress
inclus
process
start
juli
time
manuscript
submiss
patient
includ
first
patient
includ
day
registr
studi
clinicaltrialsgov
estim
last
patient
recruit
januari
